Vanguard Global Advisers’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.92M Sell
200,037
-27,749
-12% -$642K ﹤0.01% 797
2026
Q1
$5.45M Buy
+227,786
New +$5.57M ﹤0.01% 742

Other funds holding ELAN

Vanguard Global Advisers's ELAN Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Elanco Animal Health (ELAN) stake by 12% in Q2 2026, selling an estimated $642K and leaving 200,037 shares worth $4.92M. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Vanguard Global Advisers first reported a position in ELAN in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.45M in Q1 2026. 512 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Vanguard Global Advisers held 200,037 shares of Elanco Animal Health worth $4.92M as of Q2 2026.
  • Vanguard Global Advisers sold 27,749 Elanco Animal Health shares in Q2 2026, an estimated $642K.
  • Elanco Animal Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #797 holding.
  • Vanguard Global Advisers first reported a position in Elanco Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Elanco Animal Health position peaked at $5.45M in Q1 2026.
  • 512 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.